Robert Walgate

Articles by Robert Walgate

The Scientist Placeholder Image

Changing Times at the OST

The Scientist Placeholder Image

The cholera genome: an advance for science or for medicine?

The Scientist Placeholder Image

Bill Gates is opening windows on world health

The Scientist Placeholder Image

Science is for innovation, but what is the public for?

The Scientist Placeholder Image

Emerging infectious diseases transmitted electronically

The Scientist Placeholder Image

A cell of few modes

The Scientist Placeholder Image

G8 summit will discuss tropical diseases

The Scientist Placeholder Image

Barbara McClintock's research plot attacked

The Scientist Placeholder Image

Devil's in the detail of UK science boost

The Scientist Placeholder Image

Human mad cow disease rising - or is it?

The Scientist Placeholder Image

French refusal to pull up GMO "contaminated" maize splits government

The Scientist Placeholder Image

Royal Society says UK science spending halved

February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies